The critical role of SLC15A4-TASL pathway was not restricted to challenge with synthetic agonists, as it was pivotal to control chronic LCMV infection, a viral infection model whose clearance is highly dependent on TLR7, rather than RIG-I-MAVS antiviral response55,58. The gene discussed is MAVS; the disease is viral infectious disease.